Occurrence of area postrema syndrome during follow-up: phenotype and influence over NMOSD activity in LATAM in real-world settings.
Claudia PestchankerBrenda Bertado CortezMarco A Lana PeixotoJosé Ignacio GortariSheila Castro SuarezCesar Caparo ZamalloaGraciana GalianaFrancisco PeñalverVanesa Daccach MarquesKatharina MessiasLorna GalleguillosFernando GarcíaJuan I RojasLiliana PatruccoEdgardo CristianoVerónica TkachukSusana LiwackiJorge CorrealeMariano MarrodanMaría C YsraelitCarlos VrechNorma DeriFelisa LeguizamonDarío TavoliniCarolina MainellaGisela ZangaMarina Alonso SerenaEthel CiampiHerval Ribeiro Soares NetoPablo LopezEdgar Carnero ContenttiPublished in: Journal of neurology (2024)
Our findings indicate that 18.3% of NMOSD patients developed APS during the follow-up period, with most patients fulfilling criteria for severe APS. The inflammatory activity decreased after the onset of APS compared to the previous year.